CTLA4 and colorectal carcinoma: Another study conducted on 18 CRC patients, and CRC cell lines, showed a higher expression of CTLA4 in CRC tissues compared to adjacent non-CRC ones and that this expression could be altered after administering capecitabine, opening up the way for further investigations regarding treatment combinations for improving ICIs efficacy in this malignancy [73].